Cheng-Chia “Fred” Wu, MD, PhD, is a board-certified radiation oncologist and physician-scientist specializing in central nervous system cancers and sarcomas. He is an attending physician at Inova Schar Cancer Institute, practicing through Radiation Oncology Associates, and a tenure-track assistant professor at Virginia Tech, with research appointments at the Fralin Biomedical Research Institute at VTC and the Children’s National Research & Innovation Campus. His clinical practice spans pediatric and adult oncology, with a focus on central nervous system tumors, sarcomas, and precision radiation techniques including proton therapy. Dr. Wu’s research centers on translational radiation oncology and innovative therapeutic delivery. His scientific interests include focused ultrasound-enabled drug delivery across the blood-brain barrier, translational clinical investigation, and preclinical development of combination treatment strategies integrating radiation, systemic therapies, and immunotherapy. His achievements include national leadership roles with the Children’s Oncology Group, service on a national pediatric brain tumor board, and appointment to the Pediatric Scientific Advisory Board of the Focused Ultrasound Foundation. He has also been recognized as a Hannah’s Heroes St. Baldrick’s Scholar and received both an ASTRO Seed Grant and the RSNA Roentgen Resident/Fellow Research Award. Dr. Wu earned his MD/PhD in pharmacology from New York Medical College, completed a transitional year in medicine at Greenwich Hospital, and finished his radiation oncology residency at New York-Presbyterian Hospital/Columbia University Irving Medical Center, where he served as chief resident.
Assistant Professor
2024 – present
Attending Physician
2024 – present
Medical School
2005 – 2013
Residency
2013 – 2014